Transplant Diagnostics: Technologies and Global Markets - Drivers, Restraints & Opportunities

Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Transplant Diagnostics: Technologies and Global Markets" report to their offering.

The global transplant diagnostics market is segmented into two classes: nonmolecular assay and molecular assay technologies. Nonmolecular assay technologies are further segmented into serological assay and mixed lymphocyte culture (MLC) assay. The molecular assay technology market is segmented into polymerase chain reaction (PCR)-based and sequencing-based.

The global transplant diagnostics technology market is further segmented on the basis of components for in-depth analysis of the market during the analysis period (2015-2021). The market study is detailed for the transplant diagnostics market based on end users as well as application area.

This report provides:

• An overview of the global markets for transplant diagnostics.
• Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Breakdowns of the market by application, end-users, and geography.
• A look at how factors such as the high cost of instruments and limited insurance and reimbursement coverage available for transplant processes are expected to hamper the growth of the global transplant diagnostics market.
• Evaluation of novel, future approaches in terms of biomarkers, bio-printing, and organoids.
• Analyses of the market's dynamics: Drivers, restraints, opportunities.
• Profiles of major players in the field.

The following need to be taken into consideration:

• The report considers the revenue generated by the sales of products, services and software used while conducting the transplant diagnostics test. These products can be kits, reagents, devices and software tools, among others.
• The report considers revenue generated by pre-transplant as well as post-transplant tests.
• The report does not consider the revenue generated by carrying out blood tests prior to transplant procedures (which is minor and done along with counseling itself).
• Although the report is closely associated with the organ transplant market, it does not consider any organ transplant cost in any manner. It only considers diagnostics.
• The periodic tests conducted post-transplant to determine the organ health in recipients' bodies form a significant part of the revenue in the market.
  

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Global Transplant Diagnostics Market Overview

4: Transplant Diagnostics Market Analysis By Technologies

5: By Component

6: Transplant Diagnostics Market Analysis By End User

7: Transplant Diagnostics Market Analysis By Applications

8: Competitive Landscape

9: Regional Analysis

10: Patent Analysis

11: Company Profiles

Companies Mentioned:

• Abbott Laboratories
• Affymetrix Inc.
• Astellas Pharma Inc.
• Biofortuna Ltd.
• Bio-Rad Laboratories
• Caredx Inc.
• Diasorin S.P.A.
• F. Hoffmann-La Roche Ag
• Fujirebio Europe N.V.
• Gendx (Genome Diagnostics B.V.)
• Illumina Inc.
• Immucor Inc.
• Linkage Biosciences
• Luminex Corp.
• Olerup SSP AB
• Omixon Biocomputing Ltd.
• Qiagen N.V.
• Sigma-Aldrich Corp.
• Thermo Fisher Scientific Inc.
• Transplant Genomics Inc.
  

For more information about this report visit http://www.researchandmarkets.com/research/w7kp5v/transplant

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Diagnostics